Switching to duloxetine from selective serotonin reuptake inhibitors in non- or partial responders: Results from a Spanish sample

By Irene Romera   Luis Montejo Angel   Helena Delgado-Cohen   David Perahia   Ramon Domenech Josep   Inmaculada Gilaberte  

International Journal of Psychiatry in Clinical Practice, Vol. 13, Iss. 2, 2009-06 ,pp. : 100-108

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Prescribing of the antidepressant duloxetine: Can local clinical audit findings facilitate medicines management decisions?

By Ajel Khalil   Bhogal Kuljit   Baldwin David  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 2, 2008-06 ,pp. : 156-159

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Efficacy of cognitive behaviour therapy in generalized anxiety disorders. Results of a controlled clinical trial (Berlin CBT-GAD Study)

By Linden M.   Linden M.   Zubraegel D.   Baer T.  

Journal of Psychosomatic Research, Vol. 55, Iss. 2, 2003-08 ,pp. : 135-136

Elsevier

Access to resources Recommend Favorite

Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy

By Doughty J.   Baker G.A.   Jacoby A.   Lavaud V.  

Epilepsy & Behavior, Vol. 4, Iss. 6, 2003-12 ,pp. : 710-716

Elsevier

Access to resources Recommend Favorite

Interpreting Antidepressant Clinical Trials

By Sussman Norman  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 19, Iss. 4, 2007-10 ,pp. : 215-220

Informa Healthcare

Access to resources Recommend Favorite